Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
45.56
-0.73 (-1.58%)
Aug 11, 2025, 3:13 PM - Market open
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $5.86 billion as of August 11, 2025. Its market cap has increased by 23.63% in one year.
Market Cap
5.86B
Enterprise Value
4.57B
1-Year Change
23.63%
Ranking
Category
Stock Price
$45.56
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $5.86B, an increase of 481.78%. That is a compound annual growth rate of 40.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 5.96B | 71.65% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 577.46B |
| Johnson & Johnson | 418.74B |
| AbbVie | 348.10B |
| UnitedHealth Group | 231.41B |
| Abbott Laboratories | 228.93B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |